Anumana, a number one AI-driven well being know-how firm, introduced the appointment of Dr. Simos Kedikoglou as President and Chief Working Officer (COO), efficient instantly.
Additionally Learn: AI and Social Media: What Ought to Social Media Customers Perceive About Algorithms?
“Simos is a visionary chief with a deep understanding of the healthcare ecosystem and a confirmed monitor document of driving development and innovation within the medtech house”
Simos brings a distinguished monitor document in world healthcare technique, medical system commercialization, and operational management to Anumana’s government crew. In his new position, he’ll lead Anumana’s industrial operations, drive strategic partnerships, and oversee the event and execution of development initiatives to advance the corporate’s mission to rework healthcare by way of AI know-how.
“Simos is a visionary chief with a deep understanding of the healthcare ecosystem and a confirmed monitor document of driving development and innovation within the medtech house,” mentioned Maulik Nanavaty, CEO of Anumana. “We’re excited to welcome Simos to our crew as we increase our impression within the healthcare trade. His in depth expertise in medical system improvement and commercialization will assist Anumana obtain its imaginative and prescient to ship groundbreaking AI-powered options to enhance affected person outcomes.”
Simos most just lately served as CEO of Impulse Dynamics, the place he led the worldwide commercialization of the Optimizer, the primary energetic implantable system for coronary heart failure therapy. Throughout his tenure, Simos secured $350 million in funding and superior a number of medical trials, enrolling greater than 5,000 sufferers. Throughout COVID, he helped the corporate attain a $40 million income run price and expanded its industrial crew to over 150 members.
He additionally performed key roles as an Government Board Member at MedAlliance, serving to elevate $150 million and facilitate its sale to Cordis. Beforehand, he was the Company Vice President of Enterprise Improvement at Boston Scientific, managing world offers and acquisitions, and as an affiliate companion at McKinsey & Firm, advising on $45 billion in healthcare transactions.
Additionally Learn: Function of AI in Cybersecurity: Defending Digital Belongings From Cybercrime
“Anumana is on the forefront of an thrilling transformation in healthcare, and it’s an honor to hitch this modern crew,” mentioned Simos. “The chance to harness AI’s potential to rework cardiovascular care is inspiring and the potential is limitless. I’m keen to use my expertise in scaling medical applied sciences to assist Anumana obtain its daring imaginative and prescient of enhancing affected person outcomes and advancing healthcare globally.”
Simos holds a medical diploma from the College of Athens, Greece, an MBA with distinction from Harvard Enterprise College, a grasp’s in public well being from Harvard College, and is a CFA charterholder.
[To share your insights with us as part of editorial or sponsored content, please write to psen@itechseries.com]
